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Introduction
Cystatin C (CysC) is a low-molecular-weight (MW 13360),
nonglycocylated cationic basic protein consisting of 120 amino
acids and belongs to the cystatin superfamily of endogenous
cysteine proteinase inhibitors (1,2,3,4). Although serum 
creatinine concentration is the most commonly used indicator
of kidney function, it is not an accurate marker of glomerular
filtration rate (GFR), which is an important index of renal 
function in health and disease. On the other hand, the plasma
concentration of CysC has been shown to be a better marker
of GFR in both adults and children (5,6,7). CysC possesses
most of the properties of an ideal GFR test - produced by all
nucleated cells at a constant rate, it is freely filtered from 
the glomerulus and finally, is fully destroyed in the proximal
renal tubulus (5,6,7). Its rate of production is not influenced 
by inflammation or malignancy and, unlike creatinine, is 
unaffected by muscle mass, gender, or age (8,9,10). The levels
are constant from the age of 1 year onwards (8). CysC might
offer a considerable advantage in the measurement of GFR (6).
Thyroid hormones, through their general metabolic effects,
may also influence plasma CysC levels. There are limited 
studies on serum CysC levels in thyroid diseases. Thyroid
function has an impact on both CysC and creatinine 
levels. Serum CysC levels have been found to be low in
hypothyroidism and to increase when a euthyroid status is
attained. Serum creatinine levels have been demonstrated 
to be relatively high in hypothyroidism and low in 
hyperthyroidism when compared to the euthyroid state. These
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The objectives of this study were to evaluate the effects
of thyroid hormone status on CysC levels as well as to explore
whether CysC levels can be used as a marker of  peripheral
effects of thyroid  hormones, as may be needed in cases of
thyroid hormone resistance.
Methods
A total of 25 patients with permanent congenital 
hypothyroidism (thyroid aplasia, n=6; ectopic thyroid, n=11;
dyshormonogenesis, n=8) were included in the study group.
No evidence of accompaning disease was observed in any of
the children. Twenty-one age-matched healthy children
formed the control group. 
At the time of investigation, weight and height 
measurements were taken by an auxologist using standard
methods and techniques and were expressed as standard
deviation score (SDS) according to national standards (19).
Body mass index (BMI) was calculated as kg/m2 and 
also expressed as SDS using national standards (20). The
anthropometric data of the two groups are given in Table1.
Serum thyrotropin (TSH), free thyroxine (fT4), serum 
CysC and creatinine levels were studied in patients with
hypothyroidism twice - in euthyroid and hypothyroid states.
Euthyroid status was defined when patients on L-T4 therapy
had normal fT4 and decreased TSH levels compared to the
levels at onset. The children were accepted to be in a
hypothyroid status when they did not receive L-T4 therapy
and had abnormal fT4 and TSH levels. Hypothyroid 
levels were obtained either at the time of diagnosis of
hypothyroidism before initiation of therapy or after stopping 
L-T4 therapy for 4 weeks in those already receiving therapy.
The L-T4 therapy was discontinued in some patients, because
we wanted to search the underlying etiology in these
patients. These patients had been started on therapy at 
diagnosis and no tests had been done with respect to 
etiology at that time. Thus, we had an opportunity to study
CysC levels during the period off L-T4 therapy.  
Blood samples were taken in the morning in the fasting
state and in patients on therapy, before the L-T4 dose. Blood
samples were also taken from the children in the control
group in the morning for determination of serum fT4, TSH,
CysC and creatinine levels. Blood samples were immediately
centrifuged and deep frozen at -20°C until analyses. Serum
creatinine was measured on the same day. 
FT4 (pmol/L) was determined by [125I] RIA kit (Institute of
Isotopes Ltd., Budapest, Hungary) and TSH (mU/L) was
measured by IRMA using DSL-5300 kit (Diagnostic Systems
Laboratories, Texas, USA). Serum CysC was analyzed by 
particle-enhanced immunoturbidimetry (21) using the CysC
PET-kit ( DAKO, Hamburg, Germany) by auto-analyzer 
(Cobas-Mira Plus) and serum creatinine was analyzed by Jaffe
method on a Cobas Integra 800 analyzer (Roche Diagnostics,
Mannheim, Germany). Measuring range of CysC assay was
approximately 0.4-7.5 mg/L.  The limit of detection was 0.07
mg/L.  Total assay coefficient of variation (CV) was 2.0-5.9 %.
Reference intervals for serum CysC, creatinine, TSH and fT4
were taken as 0.55- 1.15 mg/L, <1mg/dL, 0.3-4.2 mIU/L and
12-22 pmol/L, respectively, according to the reference ranges
given in the kits. GFR was calculated using the Schwartz 
formula  [k (constant) x height (cm)/ serum creatinine] (22).
The study was approved by the local ethics committee.
Written informed consent was obtained from the parents of
the children in both the study group and the control group.
Statistical Analysis
Statistical analysis was done using the SPSS-PC (SSPS for
Windows, version 12.0, Chicago) package program. Mean
(±SD) values are given. Between-group comparisons were
done by the Mann-Whitney U test and t-test and within-group
comparisons were performed by the Wilcoxon signed-rank
test and paired t-test. Pearson’s correlation coefficient was
applied to detect linear correlation in the total group. A p-value
of less than 0.05 was considered statistically significant. 
Results 
At the time of investigation, the mean age  of the children
with hypothyroidism was 8.7±4.9 years (range:2.9-19.1 years)
and was not significantly different from the age of the control
group (9.7±5.0 years; range: 1.5-19.8 years). As seen in Table
1, anthropometric parameters of the two groups were not 
different from each other either. Serum fT4 (pmol/L) was
4.6±4.4 (range:0.1-12.67)  and serum TSH (mIU/L) was 201.8
± 228.3 (range:11.53-954.1) in the hypothroid status and fT4
was 20.6±3.8 (range:16.6-34.6) and TSH was 4.7±2.6
(range:0.3-10.8) in the euthyroid satus in children with primary
hypothyroidism. In some children, TSH values showed a
decrease, but were still high at the time of investigation, while
fT4 was normal, indicating a euthyroid status.Control group
had normal fT4 (pmol/L) and TSH (mIU/L)  values [17.7±2.1
(range: 13.5-22.2) and 3.1±1.1 (range:1.6-5.5), respectively],
fT4 and TSH values were in normal ranges.  
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Table 1. Anthropometric parameters of the children with 
hypothyroidism and of the controls
Children with  Controls p
hypothyroidism (n=21;12 F, 9 M)
(n=25; 15 F, 10 M)
Age (year) 8.7±4.9 9.7±5.0 0.474
Weight SDS -0.16 ± 1.4 -0.48±1.54 0.354
Height SDS -0.46±1.3 -0.66±1.67 0.589
BMI SDS -0.03±1.3 0.46±1.4  0.447
BMI: body mass index, SDS: standard deviation score As seen in Table 2, creatinine, GFR and CysC levels 
did not differ significantly between the study group in 
the euthyroid status and the control group. Comparison
between the hypo- and euthyroid states in the study group
demonstrated higher creatinine level (p=0.007), lower GFR
(p=0.023) and lower CysC (p=0.01) in the hypothyroid status
than in the euthyroid status. 
Comparison between the study group in the hypothyroid
status and the control group revealed significant differences in
the GFR (p=0.002) and in the CysC (p=0.017) levels, but the
differences were not significant between the control group
and the patients in the euthyroid status.
In the study group, serum CysC levels were not 
significant difference between boys and girls before 
treatment (0.64±0.1 vs 0.58±0.1 p=0.113), but  were 
significantly higher in boys than in girls after treatment
(0.74±0.1 vs 0.6±0.1, p=0.008).
In controls, serum CysC did not show a significant 
difference between boys and girls (0.66±0.1 vs 0.68±0.1,
p=0.862). 
Correlation Studies
There was a positive correlation between CysC and GFR
in hypothyroid status (r=0.463, p=0.02). CysC level was not
correlated to height, weight, BMI and age in both  the study
and the control group. GFR had positive correlation with fT4 in
the hypothyroid status (r=0.563, p=0.012).
Discussion 
The main finding of our study was that serum creatinine
was higher, while GFR and CysC levels were lower in
hypothyroid status when compared to the euthyroid status
and/or to normal controls. These results are consistent with
those of most of the studies investigating the effect of thyroid
status on serum CysC levels (11,12,13,14,15,16,17,18,23).
Our study was different from the previous studies in that 
it was undertaken in children with hypothyroidism, 
whereas most of the studies were conducted in adults.
Secondly,  some of the previous studies included patients
with hypothyroidism of autoimmune etiology such as 
autoimmune thyroiditis or Graves’ disease (11,12,13,14,15,
16,17,18) and, it was speculated that autoimmune 
mechanisms might also play a role in the effects of thyroid
dysfunction on CysC serum levels (1). Our study did not
include patients with autoimmune etiology, thus the effect of
thyroid status on CysC levels may be considered to be the
result of hypothyroid status per se. 
Thyroid hormones have significant effects on renal 
hemodynamics, renal handling of salt and water and on the
active tubular transport of Na+, K+ and H+ (23). It is possible
that tubular creatinine secretion is diminished in 
hypothyroidism, thereby increasing the serum creatinine 
concentrations. A slight decrease in GFR has been found in
patients with hypothyroidism, which improved significantly
after treatment (11,13,14). Thyroid hormones may influence
CysC levels by altering their production rate and/or their 
metabolic rate.  Since CysC is produced at a constant rate that
is independent of age, gender, muscle mass and external 
factors like inflammation, they may serve as markers of 
thyroid function.  Indeed, serum CysC levels were found to be
significantly correlated with fT4 in hypothyroid and euthyroid
status in our study. These findings indicate that serum CysC
levels may be a marker of thyroid function. The low levels of
CysC in hypothyroidism and the increase in serum CysC 
levels after L-T4 therapy (12,13,14,17) as well as the 
significant correlation between fT4 and CysC levels (14) has
been also shown in some adult studies.  However, changes
in serum CysC levels in these studies mostly did not exceed
the reference interval. Therefore, it was concluded that serum
CysC levels have limited use in determining the peripheral
effects of thyroid hormones (17). Similarly, in our study
although hypothyroid status lowered CysC levels and L-T4
therapy increased these levels, the fluctuations tended to
remain within normal reference interval and CysC levels 
cannot be accepted as a marker of thyroid status. 
Serum CysC levels did not show a significant difference
between boys and girls in the healthy children in our study and
this finding is consistent with the results of some studies
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Table 2. Comparison of some laboratory findings between the study group (Group 1) and the control group (Group 2) (Mean±SD)
Children with hypothyroidism p* p**
(n=25) Hypothyroid vs  Controls (n=21) Hypothyroid  Euthyroid
Hypothyroid   Euthyroid Euthyroid Status vs Controls vs Controls
Status
Creatinine (mg/dl) 0.53±0.2   0.45±0.1 0.007 0.43±0.13 0.098 0.776
GFR (ml/dk/1.73m
2) 139.8±32.2 163.5±38.8 0.023 181.4±48.5 0.002 0.112
Cystatin C (mg/L)  0.6±0.1 0.66±0.1 0.01 0.67±0.1 0.017 0.643
GFR: Glomerular filtration rate
*comparison between hypo- and euthyroid status within patient groups
**comparison between  control group and hypo- and euthyroid status (6,8,9,24,25), although gender differences were noted in
some other studies (25,26). In contrast to healthy children, in
the patients with hypothyroidism, serum CysC levels were
significantly higher in boys than in girls after treatment.
Although we do not have a clear explanation for this 
gender difference in CysC levels in hypothyroidism, we may
speculate that thyroid hormones may interact with gonadal
hormones in the production of CysC.  
There was no correlation between serum CysC levels and
age, BMI, height and weight of the children in either the study
or the control groups.   Serum CysC levels remain constant
from the age of 1 year onwards (6,8,9,24) and this offers a
considerable advantage in the evaluation of CysC levels in a
growing child. 
In conclusion, we demonstrated a significant effect of 
thyroid dysfunction on CysC levels, but the changes in serum
CysC levels in hypo- and euthyroid status did not exceed the
reference interval. It may be concluded  that serum CysC 
levels have limited use in evaluating the peripheral effects of
thyroid hormones. 
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